- Home
- MBRX vs BGI Comparison
MBRX vs BGI Comparison
Compare MBRX & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MBRX | BGI |
|---|---|---|
| Founded | 2015 | 1879 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1M | 12.8M |
| IPO Year | 2016 | 2002 |
Fundamental Metrics
Financial Performance| Metric | MBRX | BGI |
|---|---|---|
| Price | $3.37 | $0.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $61.00 | N/A |
| AVG Volume (30 Days) | ★ 327.0K | 66.7K |
| Earning Date | 05-12-2026 | 12-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.26 | $0.47 |
| 52 Week High | $7.98 | $1.57 |
Technical Indicators
Market Signals| Indicator | MBRX | BGI |
|---|---|---|
| Relative Strength Index (RSI) | 69.78 | 44.58 |
| Support Level | $3.13 | $0.47 |
| Resistance Level | $5.22 | $0.70 |
| Average True Range (ATR) | 0.23 | 0.06 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 87.60 | 54.26 |
Price Performance
Historical ComparisonAbout MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.